Table A2.
Baseline lipidomic profile.
| Lipid | Baseline Concentrations and Ratios |
|---|---|
| MAG 18:1 | 1.10 (0.56) a |
| MAG 18:2 | 0.19 (0.09) aa |
| DAG 16:1 16:1 | 0.51 (0.20) |
| DAG 16:0 16:0 | 4.89 (2.00) |
| DAG 16:0 18:2 | 8.55 (3.73) |
| DAG 16:0 18:1 | 28.16 (11.20) |
| DAG 18:2 18:2 | 1.01 (0.59) |
| DAG 18:0 18:2 | 2.77 (1.12) |
| DAG 18:1 18:1 | 60.16 (24.41) a |
| DAG 18:0 18:1 | 3.38 (1.63) b |
| DAG 18:0 20:4 | 1.11 (0.70) c |
| LPC 16:0 | 1324.83 (525.13) b |
| LPC 18:0 | 600.78 (260.70) |
| Cer C14:0 | 0.08 (0.03) b |
| Cer C16:0 | 1.26 (0.38) b,c |
| Cer C18:0 | 0.94 (0.32) aa,c |
| Cer C20:0 | 3.87 (1.25) |
| Cer C22:0 | 2.33 (0.67) b,c |
| Cer C24:0 | 9.84 (2.51) b,c |
| Cer C24:1 | 15.40 (4.60) |
| Ratio Cer C16:0/Cer C24:0 | 0.13 (0.03) |
| Ratio Cer C18:0/Cer C24:0 | 0.10 (0.03) |
| Ratio Cer C24:1/Cer C24:0 | 1.59 (0.36) |
| SM (d18:1/18:0) | 14.01 (4.49) |
| S1P | 0.40 (0.11) b |
Results shown as mean (SD); a statistical differences (p value < 0.05) between sex; aa statistical differences (p value < 0.001) between sexes; b statistical differences (p value < 0.05) between smoking status; c statistical differences (p value < 0.05) between statin treated vs. untreated participants.